NEOGENOMICS INC's ticker is NEO and the CUSIP is 64049M209. A total of 133 filers reported holding NEOGENOMICS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2020 | $260,000 | +28.7% | 7,048 | +8.1% | 0.01% | +28.6% |
| Q2 2020 | $202,000 | +29.5% | 6,519 | -45.2% | 0.01% | +16.7% |
| Q2 2018 | $156,000 | -4.3% | 11,900 | -40.3% | 0.01% | 0.0% |
| Q1 2018 | $163,000 | -7.9% | 19,940 | -0.1% | 0.01% | -14.3% |
| Q4 2017 | $177,000 | -20.3% | 19,951 | 0.0% | 0.01% | -30.0% |
| Q3 2017 | $222,000 | +20.7% | 19,951 | -2.8% | 0.01% | +25.0% |
| Q2 2017 | $184,000 | +13.6% | 20,531 | -0.1% | 0.01% | 0.0% |
| Q1 2017 | $162,000 | -23.6% | 20,560 | -16.8% | 0.01% | -27.3% |
| Q4 2016 | $212,000 | +3.9% | 24,718 | -0.2% | 0.01% | 0.0% |
| Q3 2016 | $204,000 | -0.5% | 24,759 | -3.2% | 0.01% | 0.0% |
| Q2 2016 | $205,000 | -41.8% | 25,589 | -51.0% | 0.01% | -45.0% |
| Q1 2016 | $352,000 | -14.1% | 52,175 | +0.1% | 0.02% | -4.8% |
| Q4 2015 | $410,000 | – | 52,102 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 1,614,263 | $19,613,000 | 10.60% |
| Samjo Capital LLC | 185,000 | $2,248,000 | 1.92% |
| PERKINS CAPITAL MANAGEMENT INC | 152,550 | $1,853,000 | 1.52% |
| Cowen Prime Advisors LLC | 183,500 | $2,230,000 | 0.94% |
| First Light Asset Management, LLC | 805,958 | $9,792,000 | 0.86% |
| Soleus Capital Management, L.P. | 460,000 | $5,589,000 | 0.72% |
| Greenhouse Funds LLLP | 574,956 | $6,986,000 | 0.70% |
| Bullseye Asset Management LLC | 108,054 | $1,313,000 | 0.60% |
| Ranger Investment Management | 776,428 | $9,434,000 | 0.60% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 960,832 | $11,674,000 | 0.52% |